CORT

#3683
Corcept Therapeutics Incorporated - Common Stock
0.6 9 USD
-98.98%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
0.69
0.69
Range Annuel
0.69
89.00
Changement quotidien
-98.98%
Changement Mensuel
-98.52%
Evolution sur 6 mois
-99.11%
Changement Annuel
-99.05%
Clôture Précédente
68.3 8
Open
0.6 9
Low
0.6 9
High
0.6 9
Volume
220
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
Compte de résultat Bilan Flux de trésorerie
Valeur Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM

Corcept Therapeutics Incorporated - Common Stock

Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. Corcept has focused on the adverse effects of excess cortisol, studying new compounds that may mitigate those effects. Its executive team is headed by CEO, president and director Joseph K. Belanoff, MD.

Nouvelles